528 related articles for article (PubMed ID: 28319507)
1. Recombinant Factor VIIa Is Associated With Increased Thrombotic Complications in Pediatric Cardiac Surgery Patients.
Downey L; Brown ML; Faraoni D; Zurakowski D; DiNardo JA
Anesth Analg; 2017 May; 124(5):1431-1436. PubMed ID: 28319507
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic risk of recombinant factor seven in pediatric cardiac surgery: a single institution experience.
Karsies TJ; Nicol KK; Galantowicz ME; Stephens JA; Kerlin BA
Ann Thorac Surg; 2010 Feb; 89(2):570-6. PubMed ID: 20103344
[TBL] [Abstract][Full Text] [Related]
3. [Risk assessment of thrombotic events after the use of activated factor VII].
Martínez López MC; Alcaraz Romero AJ; Martínez López AB; Fernández-Llamazares CM; Ramos Navarro C
An Pediatr (Barc); 2013 Sep; 79(3):177-81. PubMed ID: 23265723
[TBL] [Abstract][Full Text] [Related]
4. Retrospective Comparison of Recombinant Activated Factor VII Versus 4-Factor Prothrombin Complex Concentrate in Cardiac Surgical Patients.
Faraoni D; Guindi A; Ankola AA; Resheidat A; Binsalamah Z; Teruya J; Savorgnan F; Vener DF
J Cardiothorac Vasc Anesth; 2024 Feb; 38(2):388-393. PubMed ID: 38129208
[TBL] [Abstract][Full Text] [Related]
5. The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Moll JJ; Krajewski W; Jarosik P
Pediatr Crit Care Med; 2004 May; 5(3):246-50. PubMed ID: 15115562
[TBL] [Abstract][Full Text] [Related]
6. Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients.
Guzzetta NA; Russell IA; Williams GD
Anesth Analg; 2012 Aug; 115(2):364-78. PubMed ID: 22652310
[TBL] [Abstract][Full Text] [Related]
7. Recombinant factor VII is associated with worse survival in complex cardiac surgical patients.
Alfirevic A; Duncan A; You J; Lober C; Soltesz E
Ann Thorac Surg; 2014 Aug; 98(2):618-24. PubMed ID: 24968771
[TBL] [Abstract][Full Text] [Related]
8. Outcomes Following Three-Factor Inactive Prothrombin Complex Concentrate Versus Recombinant Activated Factor VII Administration During Cardiac Surgery.
Harper PC; Smith MM; Brinkman NJ; Passe MA; Schroeder DR; Said SM; Nuttall GA; Oliver WC; Barbara DW
J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):151-157. PubMed ID: 29217234
[TBL] [Abstract][Full Text] [Related]
9. Recombinant activated factor VII in cardiac surgery: single-center experience.
Singh SP; Chauhan S; Choudhury M; Malik V; Choudhary SK
Asian Cardiovasc Thorac Ann; 2014 Feb; 22(2):148-54. PubMed ID: 24585784
[TBL] [Abstract][Full Text] [Related]
10. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
[TBL] [Abstract][Full Text] [Related]
11. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
[TBL] [Abstract][Full Text] [Related]
12. Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass.
Guzzetta NA; Huch S; Fernandez JD; Tosone SR; Miller BE
Paediatr Anaesth; 2009 Apr; 19(4):364-70. PubMed ID: 19143947
[TBL] [Abstract][Full Text] [Related]
13. The safety of recombinant factor VIIa in cardiac surgery.
Mitra B; Phillips L; Cameron PA; Billah B; Reid C
Anaesth Intensive Care; 2010 Jul; 38(4):671-7. PubMed ID: 20715730
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Outcomes Using Low-Dose and Early Administration of Recombinant Activated Factor VII in Cardiac Surgery.
Brase J; Finger B; He J; Wirtz K; Stun L; McMillen R; Flynn B
Ann Thorac Surg; 2016 Jul; 102(1):35-40. PubMed ID: 26874365
[TBL] [Abstract][Full Text] [Related]
15. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
[TBL] [Abstract][Full Text] [Related]
16. Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery.
Scott JP; Costigan DJ; Hoffman GM; Simpson PM; Dasgupta M; Punzalan R; Berens RJ; Tweddell JS; Stuth EA
J Clin Anesth; 2014 May; 26(3):204-11. PubMed ID: 24809789
[TBL] [Abstract][Full Text] [Related]
17. Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery.
Agarwal HS; Bennett JE; Churchwell KB; Christian KG; Drinkwater DC; He Y; Taylor MB
Ann Thorac Surg; 2007 Jul; 84(1):161-8. PubMed ID: 17588404
[TBL] [Abstract][Full Text] [Related]
18. Impact of On-Bypass Red Blood Cell Transfusion on Severe Postoperative Morbidity or Mortality in Children.
Willems A; Datoussaid D; Tucci M; Sanchez Torres C; De Villé A; Fils JF; Van der Linden P
Anesth Analg; 2016 Aug; 123(2):420-9. PubMed ID: 27331784
[TBL] [Abstract][Full Text] [Related]
19. Off-label recombinant factor VIIa use and thrombosis in children: a multi-center cohort study.
Witmer CM; Huang YS; Lynch K; Raffini LJ; Shah SS
J Pediatr; 2011 May; 158(5):820-825.e1. PubMed ID: 21146180
[TBL] [Abstract][Full Text] [Related]
20. Recombinant activated factor VII for refractory bleeding after acute aortic dissection surgery: a propensity score analysis.
Tritapepe L; De Santis V; Vitale D; Nencini C; Pellegrini F; Landoni G; Toscano F; Miraldi F; Pietropaoli P
Crit Care Med; 2007 Jul; 35(7):1685-90. PubMed ID: 17522585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]